PharmaCyte Biotech Inc (PMCB)

[DragonBear]

Dont be surprised if PMCB and Viacyte-not happening

So now Viacyte is going to throw out 7 yrs of clinical trials:

The company’s two clinical-stage product candidates – PEC-Encap and PEC-Direct – are actively recruiting Type 1 diabetes patients for two, Phase 2 clinical trials. Data are expected in the second half of 2021 for PEC-Encap and first half of 2022 for PEC-Direct, with hopes to file biologics license applications in 2024 and 2025, respectively.

and start all over again? Yeah, that's the way to succeed in the biotech business. Create a functional "device" product, go into clinical trials, and just when the data is due to come in, pitch it out the window. And for what?

PMCB has nothing to offer Viacyte, that Viacyte doesn't already have.

If and when Viacyte develops the immune-evasive cell line, PEC-QT, then it's game over for CIAB dreams in diabetes. Along with anyone else working on an encasement system. Then a Lilly or other large pharma buys out Viacyte. And noooo... PMCB has no capabilities to produce a cell line that escapes immune detection, as Viacyte is currently developing.